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Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF). 2 
This study examines the role of organism-specific factors in the pathogenesis of very early P. 3 
aeruginosa infection in the CF airway. One-hundred-and-sixty-eight longitudinally collected P. 4 
aeruginosa isolates from children diagnosed with CF following newborn screening were genotyped 5 
by pulsed-field gel electrophoresis and phenotyped for 13 virulence factors. Associations between 6 
virulence factors and gender, exacerbation, persistence, timing of infection and infection site were 7 
assessed using multivariate regression analysis. Ninety-two strains were identified. Persistent 8 
strains showed significantly lower levels for pyoverdine, rhamnolipid, haemolysin, total protease, 9 
and swimming and twitching motility, than strains eradicated by aggressive antibiotic treatments. 10 
Initial strains had higher levels of virulence factors, and significantly higher phospholipase C, than 11 
subsequent genotypically-different strains at their initial isolation. Strains from males had 12 
significantly lower pyoverdine and swimming motility than females. Colony size was significantly 13 
smaller in strains isolated during exacerbation than those isolated during non-exacerbation periods. 14 
All virulence factors were higher and swimming motility significantly higher, in strains from 15 
bronchoalveolar-lavage (BAL) and oropharyngeal sites than BAL-alone. Using unadjusted 16 
regression modelling, age at initial infection and age at strain isolation showed U-shaped profiles 17 
for most virulence factors. Among subsequent strains, the longer the time since initial infection, the 18 
lower the level of most virulence factors. This study provides new insight into virulence factors 19 
underpinning impaired airway clearance seen in CF infants despite aggressive antibiotic therapy. 20 
This information will be important in the development of new strategies to reduce the impact of P. 21 
aeruginosa in CF. 22 
  23 
 3 
INTRODUCTION 1 
Pseudomonas aeruginosa airway infection of young children with cystic fibrosis (CF) is typically 2 
intermittent, involving multiple non-mucoid strains that are sensitive to anti-pseudomonal 3 
antibiotics. However, one strain eventually becomes established and by adolescence almost 80% of 4 
CF patients are chronically-infected, resulting in increased morbidity and mortality [1]. 5 
 6 
Many host factors affect the course of infection in the CF lung [2], but there is limited 7 
understanding about organism-specific traits affecting infectivity, severity of infection and 8 
persistence. The environment is the main source for acquiring P. aeruginosa, suggesting that 9 
environmental isolates have all the virulence determinants to initiate infection and cause disease [3]. 10 
P. aeruginosa adapts to long-term survival in the CF lung by overproducing alginate, forming 11 
biofilms and down-regulating virulence factors [4-5]. Tracking of adaptive mutations in isolates 12 
from chronically-infected adults showed defects in swimming and twitching motility, pyocyanin 13 
secretion and biofilm formation [6]. However, P. aeruginosa strains infecting infants and young 14 
children have not been systematically examined to establish the characteristics underpinning 15 
pathogenesis of early infection in the CF lung.16 
 17 
Here we present the virulence factor phenotype of 168 P. aeruginosa isolates collected 18 
longitudinally over the first five-years of life from infants diagnosed with CF after newborn 19 
screening and classified by genotyping as 92 distinct strains. The Type 3 Secretion System profiles 20 
of this cohort were published previously [7]. Relationships were sought between virulence factor 21 
expression and clinical factors. 22 
 4 
MATERIALS AND METHODS 1 
Clinical isolates 2 
Investigations were conducted on 168 P. aeruginosa isolates from 58 children aged 3-63 (mean 3 
26.8) months collected within the Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) 4 
randomised controlled trial [8]. Isolates came from 150 specimens: 57 bronchoalveolar lavage 5 
(BAL) fluid (35 children); 82 oropharyngeal (OP) swabs (44 children) and 11 sputa (9 children 6 
post-ACFBAL study). On average, 2.5 (range 1-18) isolates were tested per child. Ethics 7 
Committees of all participating hospitals approved the study. 8 
 9 
The ACFBAL study randomised infants diagnosed with CF after newborn screening to either BAL-10 
directed therapy or standard care using clinical judgment and OP cultures [8]. BAL-directed infants 11 
underwent BAL at enrolment before six-months of age, and then with exacerbations requiring 12 
hospitalisation, if OP cultures grew P. aeruginosa, and after P. aeruginosa eradication therapy. All 13 
subjects had OP cultures taken during exacerbations and after eradication therapy, while each 14 
underwent BAL at age five. Children with positive P. aeruginosa BAL (≥103 colony-forming 15 
units/ml) or OP (standard group only) cultures received two-weeks of intravenous tobramycin with 16 
either ticarcillin-clavulanate, or ceftazidime, followed by four-weeks of oral ciprofloxacin and eight 17 
weeks of nebulised tobramycin inhalation solution [8]. After treatment, BAL-directed children had 18 
further BAL and OP cultures, while those receiving standard care had OP cultures alone. If P. 19 
aeruginosa persisted, the eradication protocol was repeated, but if this also failed the child was 20 
categorised as chronically-infected. Samples were processed by hospital laboratories where P. 21 






Genotypic testing 1 
Isolates were genotyped using pulsed-field gel electrophoresis (PFGE) following SpeI digestion 2 
[10]. Analyses were performed using cluster analysis software (GelComparIITM, Applied Maths, 3 
Belgium) and the criteria of Tenover et al [11]. 4 
Phenotypic tests 5 
i. Pyocyanin Overnight P. aeruginosa grown in Cation-Adjusted Mueller-Hinton Broth 6 
(CAMHB) (Oxoid Ltd, Australia) were scored (0-4) for intensity of green pigment: 0 = no pigment, 7 
1 = light green, 2 = moderate green, 3 = dark green, 4 = very dark green [12]. 8 
ii. Pyoverdine 5µl of overnight CAMHB cultures were spotted onto Kings B agar (Oxoid), 9 
dried and incubated at 37oC. Plates were viewed under a transilluminator after 24h and scored on 10 
the intensity of the fluorescent yellow pigment produced by pyoverdine using a graded system: 0= 11 
no fluorescence, 1 = lightly fluorescent yellow, 2 = moderately fluorescent yellow, 3 = strongly 12 
fluorescent yellow, 4 = very strongly fluorescent yellow [13]. 13 
iii. Haemolysin 5µl of overnight CAMHB culture was spotted onto Columbia Horse Blood 14 
Agar (Oxoid), dried and incubated for 20h at 37oC. Two perpendicular diameters of clearance zones 15 
around colonies were measured and the area (πr2) calculated (mm2). This method was utilised in iv 16 
to viii below. 17 
iv. Total Protease 5µl of overnight CAMHB culture were spotted onto a 15%v/v skim milk 18 
agar plate dried and incubated for 24h at 37oC. 19 
v. Elastase 5µl of overnight CAMHB culture were spotted onto 10ml elastin agar plates, dried 20 
and incubated for 48h at 37oC. 21 
vi. Phospholipase C 5µl of overnight CAMHB culture were spotted onto egg yolk agar plates, 22 
dried and incubated for 20h at 37oC [14-15]. 23 
vii. Rhamnolipid 5µl of overnight CAMHB culture were spotted onto M9-based agar plates, 24 
supplemented with 0.2% (v/v) glucose, 2 mM MgSO4, 0.05% (v/v) tyrosine, 0.0005% (v/v) 25 
 6 
methylene blue, 0.02% (v/v) and cetyltrimethylammonium bromide dried and incubated for 48h at 1 
37oC. Colonies were scored as positive by the presence of a violet halo around the colony. 2 
viii. Twitching and swimming motilities Bacterial patches from 1.5%w/v Luria plates were 3 
scraped with a toothpick and stab inoculated into 10ml (1%w/v Luria-broth) agar. Twitching 4 
motility (light haze of growth at the agar/plate interface) was measured after 24h at 37oC. For 5 
swimming, toothpick scrapings were spotted onto centre of a swim (0.3%w/v Luria-broth) plate and 6 
swim diameters measured after overnight at 30oC. 7 
ix. Swarming motility Pre-warmed swarm plates (0.8%w/v nutrient broth, 0.5%w/v agar and 8 
0.5%w/v glucose) were inoculated with a colony tooth-picked from a swim plate (above). After 24h 9 
at 37oC, swarming motility was identified as spreading growth from the inoculation site and graded 10 
0-4 where; 0 = no motility, 1= very limited motility. 2 = fair motility, 3 = strongly motile, 4 = very 11 
strongly motile. 12 
x. Biofilm mass 107 cells were inoculated into wells of a microtitre plate containing 100µl 13 
CAMHB and plates incubated for 24h at 37oC. Biofilm mass was stained with 1%v/v crystal violet, 14 
ethanol-extracted and absorbance read at OD595. Readings were then normalised as a percentage of 15 
P. aeruginosa PAO1 biofilm grown concurrently. 16 
xii. Colony size 100µl aliquots of a 10-7 dilution of overnight P. aeruginosa culture were spread 17 
onto CAMHB plates and incubated at 37oC. Colony diameter was measured in mm after 24h. 18 
xiii. Mucoidy Cells were scraped from 1.5%w/v Luria-broth patch plate, then patched onto 19 
5%v/v glycerol MacConkey plates (Oxoid) and scored (+/-) for mucoidy after 48h at 37oC. 20 
 21 
Statistical analysis 22 
Patients were followed longitudinally. Each isolate was tested (×3) for each outcome of interest. 23 
Nine continuous and three categorical measures of virulence (measured using semi-quantitative 24 
scores from 0-to-4) were analysed. These scores were categorised into binary variables to assess the 25 
 7 
likelihood of having a score of 3 or 4 versus any score below 3. As only four isolates were mucoid, 1 
statistical analysis was not conducted on the fourth categorical measure (mucoidy). 2 
 3 
The associations between a set of independent factors and each of the virulence measures were 4 
assessed using multivariate regression analysis. The independent factors were gender, exacerbation 5 
at sample collection time, initial vs subsequent strain infection, persistent strain (defined as one 6 
detected continuously or intermittently for at least three-months) and site of sample isolation (BAL 7 
only, BAL+OP, OP-only).  8 
 9 
We further investigated whether: i) the child’s age at acquisition of first infection, ii) the age of the 10 
child at the collection of a strain and iii) time since acquisition of the first strain, had any effect on 11 
the outcomes of interest. The associations between these three time-related variables and each of the 12 
virulence measures were estimated separately using unadjusted regression analysis. 13 
 14 
Population-averaged panel-data regression models and generalized estimation equations (GEE) 15 
were used to assess the associations of interest. Linear or logistic regression was used depending on 16 
the measure of the outcome of interest. Regression analyses were executed using STATA 12.0 17 
(StataCorp, College Station, TX, USA). 18 
 8 
RESULTS 1 
The 58 children fell into three categories. Twenty-eight had only one strain detected on a single 2 
occasion; 10 had one strain detected on multiple occasions and the remaining 20 had multiple 3 
strains detected on multiple occasions. 4 
Genotype 5 
Ninety-two strains were identified by PFGE. Of these, 90 strains had unique pulsotypes, while the 6 
remaining two strains had macrorestriction patterns indistinguishable from Aust-01 and Aust-02, 7 
which are highly-prevalent strains found frequently in older, chronically infected patients attending 8 
Australian CF clinics [16]. Only one patient had Aust-01, and another two had the Aust-02 strain 9 
identified. Since transmissibility and other properties of these clonal strains may have biased 10 
results, all analyses were repeated without them and results remained comparable (data not shown). 11 
 12 
Of the 92 strains, 52 (56.5%) were initial infecting strains detected in children at an average age of 13 
26.8 (range 3-63, standard deviation 14.6) months. Seventy-three strains (79.3%) came from an 14 
exacerbation, 22 strains (23.9%) were persistent (14 were persistent from the initial infection and 15 
eight from a subsequent infection), 59 (64.1%) cleared, while the persistence of 11 (12.0%) strains 16 
was unknown as genotyping was limited to the available sample set. Thirty-five strains were from 17 
the upper airways (OP) only, 31 from the lower airways collected by BAL and 18 were found in 18 
both sites (eight strains from follow-up sputa were excluded from analyses for site, as the quality of 19 
these specimens was unknown and they may have contained both upper and lower airway isolates). 20 
Phenotype 21 
Pyocyanin was scored at 3 or 4 in 20.5% of the tests, pyoverdine was scored at 3 or 4 in 31.8% of 22 
the tests and swarming was scored at 3 or 4 in 12.6% of the tests. The distributions of all continuous 23 




Persistent strains versus cleared strains 1 
Multivariate analysis (Table 2) showed that the levels of six virulence factors: pyoverdine, 2 
rhamnolipid, haemolysin, total protease and swimming and twitching motilities were significantly 3 
lower in persistent strains compared to cleared strains, while another six factors; pyocyanin, 4 
elastase, phospholipase C, biofilm mass, colony size and swarming motility showed non-significant 5 
reductions. No factor was significantly higher in persistent strains compared to cleared strains. 6 
 7 
Effects of gender, timing of isolation, site of infection and exacerbation on phenotype 8 
With respect to gender, pyoverdine expression and swimming motility were significantly lower in 9 
strains from males compared to females (Table 2). In comparisons of initial and subsequent 10 
(genotypically-different) strains at their first isolation, initial strains had higher expression of all 11 
virulence factors, except pyocyanin, and this reached statistical significance for phospholipase C. 12 
All virulence factors showed an increase in strains from both OP and BAL compared to BAL-only, 13 
while swimming motility was significantly higher. Only smaller colony size was associated with 14 
exacerbation. 15 
 16 
Influence of age of child and time of isolation on phenotype 17 
Table 3 shows changes in virulence factor expression and Figure 1 shows the changes for the eight 18 
clearance-zone based measurements, with respect to: age at initial strain isolation, age at isolation of 19 
a strain and time since initial strain isolation.  20 
 21 
Age at initial strain isolation: Phospholipase C, haemolysin and total protease levels were 22 
significantly lower in initial strains acquired at age 12-23 months compared with ≤12-months, but 23 
were not different at age >36-months compared with ≤12-months (Table 3, part 1). Pyoverdine and 24 
swarming motility were lower in initial strains acquired at 24-35 months compared with ≤12-25 
months, but were the same at ≥36 months as at ≤12 months. Biofilm mass increased with age of 26 
 10 
initial strain isolation, becoming significant at 24-35 months. Of the eight virulence factors 1 
measured by area of clearance zone, all except biofilm mass produced a non-linear, non-monotonic 2 
U-shaped curve (Figure 1A). 3 
 4 
Age at isolation of a strain: Expression of pyoverdine and haemolysin, and colony size were 5 
significantly lower in strains from children aged 24-35-months compared to children aged 6 
≤12months. Total protease expression was significantly lower in both 12-23 and 24-35-month-old 7 
children compared with children aged ≤12months (Table 3, part 2). Of the eight virulence factors 8 
measured by area of clearance zone (Figure 1B) all except swimming and twitching motility gave a 9 
U-shaped effect.  10 
 11 
Time since isolation of initial strain; The longer the time, the lower the level of most virulence 12 
factors (Table 3, part 3). Significant decreases occurred for biofilm mass and swimming motility by 13 
age 11-months, for twitching motility and colony size by 23-months and for elastase, phospholipase 14 
C, haemolysin and total protease by >36-months. Figure 1C, shows an initial fall, followed by a 15 
stable period, with a sharp decline at >36-months, for all factors except rhamnolipid. The presence 16 
of subsequent infections does not explain the sharp decline in virulence observed in the ≥36 17 
month’s group. Subsequent strains were isolated from patients between 2 and 97 months after initial 18 
strains (mean=22.8 months, median=15 months), meaning that most subsequent infections occurred 19 









P. aeruginosa virulence factors are usually associated with acute infection within the host. The 2 
complex relationships between virulence factor expression and pathogenesis of airway infection in 3 
CF have been investigated mainly in chronically infected adults [17-19]. Our study is the first to 4 
comprehensively examine P. aeruginosa virulence factor expression profiles in CF infants and 5 
young children. 6 
Virulence versus persistence, initial/subsequent strain, gender, exacerbation and site of infection 7 
This study provides the first evidence that virulence factor expression profiles of P aeruginosa 8 
strains at their first isolation in the CF airway of young children may help predict the ability of the 9 
strain to persist in the face of the immune response and antibiotic therapy. Expressions of 10 
pyoverdine, rhamnolipid, haemolysin, total protease and swimming and twitching motilities were 11 
all significantly lower in persister than clearer strains and this finding was independent of potential 12 
confounders such as site of isolation (upper or lower airway) and whether the airway was P. 13 
aeruginosa naive or potentially damaged by a previous P. aeruginosa strain. Since these persister 14 
strains were not clonally related to each other or to frequent clones circulating in Australian clinics 15 
they are assumed to have been environmentally acquired. P. aeruginosa is known to down-regulate 16 
these virulence factors as a survival mechanism in the CF lung [17, 20].  However it seems unlikely 17 
that such adaptations begin so early in the infection process. Perhaps instead some environmental 18 
strains first colonise the sinuses where adaptation to the local microenvironment takes place before 19 
aspiration into the lower airways occurs. Studies show pyoverdine-negative mutants increase with 20 
lung colonisation time [21], which would indicate that persisters do not have a greater requirement 21 
for pyoverdine. Rhamnolipid is a biosurfactant involved in protecting cells against oxidative stress 22 
[22] and in increased swarming [23]. It is also cytotoxic to eukaryotic cells, decreases liquid surface 23 
tension and facilitates access to nutrients within biofilms [24-25]. Since these functions are 24 
important in long-term bacterial survival, the down regulation of rhamnolipid is noteworthy. 25 
Decreased haemolysin expression has been correlated with increased mucoidy [26], however all 26 
 12 
persistent strains in our study were non-mucoid. Some bacterial proteases promote mucoidy [27], so 1 
strains may begin to display mucoidy as persistence continues. 2 
 3 
The overall virulence profiles of initial strains were higher than those of subsequent strains at their 4 
first isolation. In particular, phospholipase C was significantly higher in initial strains. 5 
Phospholipase C is a heat-labile lecithin-degrading haemolysin. The phospholipase C/sphingo-6 
myelinase gene-pair acts as an inhibitor of lung pulmonary surfactant [28], thus phospholipase C 7 
may be required to establish the initial, but not subsequent infection. 8 
 9 
Associations with gender proved interesting. Previous reports had indicated high virulence factor 10 
expression during early CF lung disease played a role in the worse prognosis of females [29], 11 
however there was no evidence of this in our analysis. The significance of the lower pyoverdine 12 
expression and lower swimming motility in strains from males is unknown. There was a lack of 13 
association between virulence factor expression and exacerbation other than for colony size, and 14 
this was at odds with our early study of CF where higher extracellular enzyme levels were found in 15 
hospitalised than non-hospitalised CF adolescent patients with chronic P. aeruginosa infection [30]. 16 
We found no significant associations between expression and site of infection, except for swimming 17 
motility being greater in strains from both BAL and OP than those from BAL-alone. These 18 
conflicting results could reflect differences in age, disease stage and the small number of non-19 
exacerbation samples. 20 
 21 
Flagella and pili-driven twitching motility are required for biofilm formation [31]. Alternatively, 22 
swarming motility is inversely proportional to biofilm formation [32]. Our finding that swarming 23 
motility and biofilm mass were not significantly different, while twitching and swimming motility 24 
were significantly reduced in persisters highlights differences between early persisters in young 25 
children and chronic infection in CF adults where biofilm formation is a distinctive feature [33]. 26 
 13 
Influence of age of child and time of isolation on phenotype 1 
Particularly noteworthy were associations between age and virulence factor expression (Table 3 and 2 
Figures 1A 1B 1C). The initial reduction in virulence factor production with increasing age of initial 3 
infection (Figure 1A) could be an adaptation to the host immune response. However, the increase in 4 
almost all factors in initial strains in the older age groups was unexpected. This was particularly 5 
marked for haemolysin, which appears independent of age of acquiring the initial strain. A U-6 
shaped curve was also evident in the analyses of virulence by age at isolation of a strain (Figure 7 
1B), with strains from children >36-months showing a modest rise after an initial fall for all factors 8 
except swimming and twitching motilities, and haemolysin again showing a significant fall at 24-35 9 
months followed by a rise at ≥36 months. While we are unsure of the reasons for this U-shaped 10 
effect, the fall in virulence factor expression seen in new P. aeruginosa isolates from older children, 11 
could offer a partial explanation. As the sinuses develop and grow in CF children, they may act as a 12 
reservoir for initial and newly acquired P. aeruginosa strains, where adaptation to the lung 13 
environment may already begin prior to them infecting lower airways [34-35]. 14 
 15 
In contrast, results of the analyses examining time since isolation of initial strain (Figure 1C), which 16 
showed significant decreased expression for eight of the twelve virulence factors by the ≥36 month 17 
time period. The significant decreases start from the earliest time point (1-11 months) in the case of 18 
biofilm mass and swimming. These results are comparable to those found by a study of P. 19 
aeruginosa isolates from CF children of undisclosed ages [36], except that this trend was evident at 20 
24 months compared with over >36-months in our study. Interestingly, four virulence factors, 21 
(pyocyanin, pyoverdine, swarming and rhamnolipid) remained virtually unchanged over the entire 22 
period. 23 
 24 
This study provides important new information on factors influencing virulence factor expression of 25 
P aeruginosa infecting the CF airway in the first years of life. While it is generally accepted that P. 26 
 14 
aeruginosa loses its virulence in the transition to chronic infection in CF, our results which show a 1 
a diverse range of up and downregulation as well as maintenance of expression amongst the twelve 2 
virulence factors over time, challenge this view. It seems likely that there is considerable diversity 3 
within microbial population evolution, with some strains retaining or enhancing virulence and 4 
others losing virulence over time. Our data suggest that this process begins within 36 or so months 5 
after initial infection. 6 
 7 
Our findings may help in understanding which virulence factors are important in establishing 8 
infection in CF infants where, despite aggressive antibiotic therapy, impaired airway clearance 9 
mechanisms exist. This is turn will be important in developing new more effective strategies to 10 
reduce the impact of P. aeruginosa on morbidity and mortality in CF. 11 
 15 
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Variable Mean  Std. Dev. Min Max 
Elastase (mm2) 82.8 40.5 0 144.0 
Rhamnolipid (mm2) 60.7 28.0 0 125.3 
Haemolysin (mm2) 84.8 63.2 0 233.1 
Total Protease (mm2) 87.1 30.2 0 134.4 
Phospholipase C (mm2) 90.4 39.0 0 155.0 
Biofilm mass (% of PAO1 biomass) 88.6 49.0 11.3 358.3 
Swimming (mm2) 69.6 35.5 0 198.8 
Twitching (mm2) 60.6 43.2 0 136.5 
Colony Size (diameter in mm) 2.6 1.3 0.5 6.0 
 18 
Table 2: Multivariate analysis of associations between a set of independent variables and individual virulence factors 1 
 2 
Independent variables Pyoverdine Pyocyanin Swarming Elastase 
ORa (95% CI) ORa (95% CI) ORa (95% CI) AECb (95% CI) 
Gender: Male vs Female 0.48  (0.23-0.99)* 0.87  (0.36-2.11) 0.50 (0.18-1.41) -5.55  (-19.6-8.85) 
Exacerbation: Yes vs No 0.53  (0.20-1.42) 1.48  (0.42-5.13) 0.65 (0.21-2.02) -8.9  (-26.58-8.79) 
Strain: Initial vs Subsequent 1.64  (0.55-4.89) 0.55  (0.16-1.88) 1.62 (0.28-9.34) 17.84  (-3.84-39.52) 
Strain: Persister vs clearer 0.21  (0.08-0.56)** 0.77  (0.27-2.17) 0.50 (0.16-1.55) -11.03  (-28.40-6.34) 
Sample: OP vs BAL 1.34  (0.43-4.16) 1.53  (0.39-5.99) 0.40  (0.07-2.20) 3.7  (-17.88-25.27) 
Sample: (BAL+OP) vs BAL 3.28  (0.83-12.88) 3.27  (0.05-12.9) 1.48  (0.31-7.05) 8.0  (-16.89-32.90) 
Independent variables Total Protease Rhamnolipid PLCc Haemolysin 
  AECb (95% CI) AECb (95% CI) AECb (95% CI) AECb (95% CI) 
Gender: Male vs Female 2.75 (-7.23-12.7) -6.99 (-16.40-2.42) 7.0 (-6.12-20.12) -2.32  (-23.2-18.56) 
Exacerbation: Yes vs No -3.49  (-16.1-9.11) -1.6  (-13.48-10.28) -8.05  (-24.61-8.51) -12.13  (-38.48-14.22) 
Strain: Initial vs Subsequent 11.37  (-4.08-26.82) 9.25  (-5.31-23.83) 26.08  (5.78-46.39)* 15.99  (-16.31-48.3) 
Strain: Persister vs clearer -12.92 (-25.30--0.54)* -12.32  (-23.99--0.64)* -9.72  (-25.99-6.55) -32.93  (-58.82--7.04)* 
Sample: OP vs BAL 3.03  (-12.34-18.40) -4.87  (-19.37-9.63) -7.8  (28.1-12.40) -10.1  (-42.24-22.06) 
Sample: (BAL+OP) vs BAL 10.63 (-7.10-28.37) 8.42  (-8.31-25.15) 2.79 (-20.52-26.10) 19.54 (-17.55-56.63) 
Independent variables Swimming Twitching Biofilm Mass Colony Size 
  AECb (95% CI) AECb (95% CI) AECb (95% CI) AECb (95% CI) 
Gender: Male vs Female -13.95  (-25.55--2.36)* -2.71  (-17.14-11.71) 1.19  (-16.34-18.72) 0.23  (-0.04-0.5) 
Exacerbation: Yes vs No 0.3   (-14.33-14.94) 2.98  (-15.22-21.19) -14.32  (-37.86-9.21) -0.4  (-0.74--0.07)* 
Strain: Initial vs Subsequent 16.90  (-1.04-34.84) 21.61  (-0.7-43.9) 14.76  (-11.7-41.22) 0.11  (-0.3-0.53) 
Strain: Persister vs clearer -24.76  (-39.13--10.4)*** -29.4  (-47.3--11.54)*** -14.83  (-37.13-7.45) -0.18  (-0.51-0.16) 
Sample: OP vs BAL -10.61  (-28.47-7.24) -4.5  (-26.71-17.7) -3.32  (-30.15-23.51) -0.28  (-0.69-0.13) 
Sample: (BAL+OP) vs BAL 22.97  (2.37-43.56)* 19.97  (-5.66-45.59) 1.39  (-30.17-32.95) 0.04  (-0.43-0.52) 
a OR = Odds Ratio b AEC = Average Expected Change c Phospholipase C 3 
*p<0.05; ** p<0.01; ***p<0.001 4 
 19 
Table 3: Change in virulence factor expression over time 1 
      Part 1: Age at initial strain isolation 2 
Virulence factor Units <12mths 12-23mths pvaluea 24-35mths pvaluea 36+mths pvaluea 
Pyocyanin % 23.08 26.79 0.720 12.12 0.271 4.35 0.069 
Pyoverdine % 42.31 28.57 0.207 20.20 0.057† 46.38 0.767 
Swarming % 12.8 14.3 0.850 2.0 0.027* 17.4 0.643 
Elastase mm2 85.27 72.63 0.158 89.45 0.672 102.44 0.112 
Rhamnolipid mm2 65.23 59.85 0.412 59.22 0.407 68.50 0.679 
PLCb mm2 97.26 79.52  0.044* 92.92 0.656 114.04 0.115 
Haemolysin mm2 103.78 71.50  0.017* 69.53     0.008** 132.45 0.080 
Total Protease mm2 94.52 80.15  0.026* 85.66 0.213 102.28 0.317 
Biofilm Mass %c 73.47 83.05 0.402 110.14     0.004** 90.11 0.265 
Swimming mm2 70.40 72.12 0.836 66.33 0.658 74.20 0.705 
Twitching mm2 67.82 53.53 0.167 63.76 0.723 66.69 0.928 
Colony Size mm 2.5 2.83 0.077 2.49 0.941 2.74 0.288 
 Part 2: Age at isolation of a strain 
Virulence factor Units <12mths 12-23mths pvaluea 24-35mths pvaluea 36+mths pvaluea 
Pyocyanin % 28.57 33.33 0.752 17.39 0.372 14.75 0.238 
Pyoverdine % 54.76 36.67 0.245 18.12   0.008** 34.43 0.152 
Swarming % 14.3 13.3 0.932 8.0 0.477 15.3 0.924 
Elastase mm2 94.33 75.31 0.147 80.82 0.275 85.28 0.451 
Rhamnolipid mm2 63.86 58.86 0.574 55.33 0.309 64.84 0.904 
PLCb mm2 101.29 85.21 0.200 85.01 0.169 94.43 0.550 
Haemolysin mm2 115.72 87.01 0.137 56.49     0.001** 98.03 0.317 
Total Protease mm2 100.41 81.45   0.047* 81.51   0.036* 91.07 0.285 
Biofilm Mass %c 85.28 83.14 0.894 88.46 0.832 92.29 0.634 
Swimming mm2 74.37 72.51 0.871 70.12 0.696 66.72 0.469 
Twitching mm2 81.43 64.42 0.221 60.70 0.114 53.09 0.031* 
Colony Size mm 3.07 2.95 0.626 2.54    0.025* 2.44 0.006** 
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Part 3: Time since isolation of initial strain 
Virulence factor Units 0mths 1-11mths pvaluea 12-23mths pvaluea 24-35mths pvaluea +36mths pvaluea 
Pyocyanin % 18.03 20.00 0.822 19.05 0.918 0.00 0.061 33.33 0.202 
Pyoverdine % 40.98 26.67 0.180 25.40 0.171 18.18 0.166 26.67 0.309 
Swarming % 13.7 11.1    0.725 4.8 0.292 18.2 0.695 8.9 0.552 
Elastase mm2 89.88 79.36 0.203 89.20 0.942 100.84 0.367 49.75 0.000*** 
Rhamnolipid mm2 62.07 59.60 0.690 60.23 0.794 66.77 0.607 66.93 0.545 
PLCb mm2 97.72 88.68 0.287 95.62 0.827 96.20 0.903 65.56 0.003** 
Haemolysin mm2 96.88 76.96 0.147 83.34 0.385 90.92 0.767 59.88 0.037* 
Total Protease mm2 91.50 84.34 0.249 88.99 0.722 94.35 0.755 73.82 0.028* 
Biofilm Mass %c 95.07 70.61   0.033* 92.71 0.850 100.82 0.721 85.02 0.480 
Swimming mm2 78.01 61.71   0.034* 68.68 0.284 75.34 0.812 58.90 0.054† 
Twitching mm2 70.96 62.13 0.354 45.34  0.018* 55.89 0.282 42.67 0.054† 
Colony Size mm 2.86 2.83 0.874 2.43  0.027* 2.64 0.375 1.93 0.000*** 
a Wald statistic; p values obtained from unadjusted regression analysis b Phospholipase C  c % of P. aeruginosa PAO1 biofilm grown concurrently 1 
* p<0.05; ** p<0.01; ***p<0.001; †borderline p<0.052 
